GPT and kidney disorder: In model II (adjusted for age; gender; HR; SBP; DBP; RR; ALT, AST, total bilirubin; total calcium; chloride; creatinine; glucose; hemoglobin; INR; PLT; PT; PTT; potassium; sodium; urea nitrogen; WBC; renal disease; CAD; diabetes; hypertension; APAHCEII; SOFA), with each 1mg/dl increment in serum phosphate, the risk of 28-day mortality increased by 79% (OR=1.79, 95%CI: 1.22–2.62, P=0.003).